Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data

BACKGROUND: Treatment with onabotulinumtoxin A (BT-A) is safe and effective for chronic migraine (CM). Several studies assessed possible predictors of response to treatment with BT-A, but there is little knowledge on the frequency and predictors of sustained response. The aim of this study was to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ornello, Raffaele, Guerzoni, Simona, Baraldi, Carlo, Evangelista, Luana, Frattale, Ilaria, Marini, Carmine, Tiseo, Cindy, Pistoia, Francesca, Sacco, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183653/
https://www.ncbi.nlm.nih.gov/pubmed/32334534
http://dx.doi.org/10.1186/s10194-020-01113-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183653/
https://www.ncbi.nlm.nih.gov/pubmed/32334534
http://dx.doi.org/10.1186/s10194-020-01113-6

Ejemplares similares